TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 294 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $33,391,605 | -19.9% | 2,125,500 | -15.9% | 0.10% | -23.3% |
| Q1 2023 | $41,674,575 | -4.0% | 2,528,797 | -9.1% | 0.13% | -12.8% |
| Q4 2022 | $43,410,120 | +103.9% | 2,782,700 | +114.1% | 0.15% | +57.4% |
| Q3 2021 | $21,292,000 | -8.1% | 1,299,900 | -5.6% | 0.09% | -9.6% |
| Q2 2021 | $23,175,000 | +95.5% | 1,377,000 | +111.4% | 0.10% | +79.3% |
| Q4 2020 | $11,854,000 | +157.6% | 651,300 | +143.4% | 0.06% | +107.1% |
| Q3 2019 | $4,602,000 | -76.9% | 267,562 | -72.6% | 0.03% | -68.9% |
| Q1 2019 | $19,892,000 | – | 976,514 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TFG Asset Management GP Ltd | 1,903,662 | $29,449,652 | 5.37% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,736,416 | $26,862,356 | 4.12% |
| Y.D. More Investments Ltd | 1,381,550 | $21,372,579 | 4.11% |
| Clean Yield Group | 533,157 | $8,167,965 | 3.62% |
| XY Capital Ltd | 143,697 | $2,222,993 | 1.28% |
| Mondrian Investment Partners LTD | 4,081,715 | $61,225,725 | 1.26% |
| Capricorn Fund Managers Ltd | 204,892 | $3,169,679 | 1.10% |
| Legacy Wealth Asset Management, LLC | 124,967 | $1,933,239 | 0.71% |
| HAP Trading, LLC | 263,679 | $4,079,114 | 0.65% |
| BRANDES INVESTMENT PARTNERS, LP | 1,802,036 | $27,877,493 | 0.54% |